Susan Cohn to Retreatment
This is a "connection" page, showing publications Susan Cohn has written about Retreatment.
Connection Strength
0.035
-
Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma. Clin Cancer Res. 2018 12 15; 24(24):6142-6149.
Score: 0.035